These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16607479)

  • 21. Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in Mozambique.
    San Lio MM; Carbini R; Germano P; Guidotti G; Mancinelli S; Magid NA; Narciso P; Palombi L; Renzi E; Zimba I; Marazzi MC
    Clin Infect Dis; 2008 May; 46(10):1609-16. PubMed ID: 18419498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M; Koffi CK
    AIDS; 2007 Aug; 21(13):1799-803. PubMed ID: 17690579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 100% adherence study: educational workshops vs. video sessions to improve adherence among ART-naïve patients in Salvador, Brazil.
    Sampaio-Sa M; Page-Shafer K; Bangsberg DR; Evans J; Dourado Mde L; Teixeira C; Netto EM; Brites C
    AIDS Behav; 2008 Jul; 12(4 Suppl):S54-62. PubMed ID: 18512141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Literacy, self-efficacy, and HIV medication adherence.
    Wolf MS; Davis TC; Osborn CY; Skripkauskas S; Bennett CL; Makoul G
    Patient Educ Couns; 2007 Feb; 65(2):253-60. PubMed ID: 17118617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the substitution of one nucleoside analogue by one non-nucleoside reverse transcriptase inhibitor over mitochondrial DNA levels.
    De Felipe B; Blanco A; Soriano-Sarabia N; Muñoz-Fernández MA; Genebat M; Vallejo A; Leal M
    Infection; 2008 Jun; 36(3):266-70. PubMed ID: 18463785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virological suppression achieved with suboptimal adherence levels among South African children receiving boosted protease inhibitor-based antiretroviral therapy.
    Müller AD; Myer L; Jaspan H
    Clin Infect Dis; 2009 Jan; 48(1):e3-5. PubMed ID: 19025495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viraemia and HIV-1 drug resistance mutations among patients receiving antiretroviral treatment in Mozambique.
    Maldonado F; Biot M; Roman F; Masquelier C; Anapenge M; Bastos R; Chuquela HC; Arendt V; Schmit JC; Zachariah R
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):607-12. PubMed ID: 18804251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV clinic improves medication adherence. DOT is latest experimental strategy.
    AIDS Alert; 2005 Mar; 20(3):28-9. PubMed ID: 15789471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
    Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).
    Pujari S; Patel A; Joshi SR; Gangakhedkar R; Kumarasamy N; Gupta SB;
    J Assoc Physicians India; 2008 May; 56():339-48, 353-71. PubMed ID: 18700643
    [No Abstract]   [Full Text] [Related]  

  • 32. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.
    Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Piyavong B; Chumpathat N; Chantratita W
    Clin Infect Dis; 2007 Feb; 44(3):447-52. PubMed ID: 17205457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations.
    Bova CA; Fennie KP; Knafl GJ; Dieckhaus KD; Watrous E; Williams AB
    AIDS Behav; 2005 Mar; 9(1):103-10. PubMed ID: 15812617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Received social support, self-efficacy, and finding benefits in disease as predictors of physical functioning and adherence to antiretroviral therapy.
    Luszczynska A; Sarkar Y; Knoll N
    Patient Educ Couns; 2007 Apr; 66(1):37-42. PubMed ID: 17097259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
    J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
    Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
    Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy.
    Byakika-Tusiime J; Oyugi JH; Tumwikirize WA; Katabira ET; Mugyenyi PN; Bangsberg DR
    Int J STD AIDS; 2005 Jan; 16(1):38-41. PubMed ID: 15705271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perceived barriers to adherence as described by individuals with HIV disease.
    Wurth S
    Ky Nurse; 2005; 53(1):11. PubMed ID: 15748005
    [No Abstract]   [Full Text] [Related]  

  • 40. Pillboxes and antiretroviral adherence: prevalence of use, perceived benefits, and implications for electronic medication monitoring devices.
    Kalichman SC; Cain D; Cherry C; Kalichman M; Pope H
    AIDS Patient Care STDS; 2005 Dec; 19(12):833-9. PubMed ID: 16375615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.